Overview
Yoshihiro Ojima practices practicing medicine in Sumiyoshi, Japan.
His clinical expertise encompasses Acute Megakaryoblastic Leukemia.
He is actively involved in clinical research, co-authoring 37 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yoshihiro Ojima
Is Yoshihiro Ojima a top-rated expert for Acute Megakaryoblastic Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Yoshihiro Ojima is classified as an Experienced expert for Acute Megakaryoblastic Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yoshihiro Ojima participate in research or clinical trials?
Yes. Yoshihiro Ojima has published 37 articles and abstracts on conditions like Acute Megakaryoblastic Leukemia. You can view a list of Yoshihiro Ojima's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Megakaryoblastic LeukemiaMr. Ojima isExperienced. Learn about Acute Megakaryoblastic Leukemia.